
    
      Despite antibiotic prophylaxis and improvements in surgical techniques, surgical site
      infections (SSI) still occur. DFA-02 is a novel bioresorbable modified release gel containing
      both gentamicin and vancomycin to be applied during surgical incision closure for the
      prevention of surgical site infections (SSIs) in patients undergoing colorectal surgery.
    
  